1. Home
  2. MREO vs NSAI Comparison

MREO vs NSAI Comparison

Compare MREO & NSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

SELL

Current Price

$0.30

Market Cap

50.3M

Sector

Health Care

ML Signal

SELL

NSAI

NorthStrive Acquisition Corp I. Class A Ordinary Shares

N/A

Current Price

$9.94

Market Cap

47.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
MREO
NSAI
Founded
2015
2026
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.3M
47.9M
IPO Year
2017
2026

Fundamental Metrics

Financial Performance
Metric
MREO
NSAI
Price
$0.30
$9.94
Analyst Decision
Buy
Analyst Count
8
0
Target Price
★ $1.96
N/A
AVG Volume (30 Days)
★ 632.5K
45.8K
Earning Date
11-09-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
★ 16.67
N/A
EPS
N/A
★ N/A
Revenue
★ $500,000.00
N/A
Revenue This Year
$59.51
N/A
Revenue Next Year
$2,326.81
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$9.82
52 Week High
$2.37
$10.00

Technical Indicators

Market Signals
Indicator
MREO
NSAI
Relative Strength Index (RSI) 50.90 55.70
Support Level $0.27 $9.82
Resistance Level $0.35 $9.94
Average True Range (ATR) 0.02 0.02
MACD 0.00 0.01
Stochastic Oscillator 62.55 45.45

Price Performance

Historical Comparison
MREO
NSAI

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About NSAI NorthStrive Acquisition Corp I. Class A Ordinary Shares

NorthStrive Acquisition Corp I is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.

Share on Social Networks: